Canonical structures of short CDR-L3 in antibodies

Proteins: Structure, Function and Bioinformatics

Volumn 82, Issue 8, 2014, Pages 1668-1673

  Teplyakov, Alexey ^a   Gilliland, Gary L ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Canonical structure; CDR conformation; Cis isomer; Crystal structure; Structure prediction

Indexed keywords

PROLINE; ANTIBODY; COMPLEMENTARITY DETERMINING REGION; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN VARIABLE REGION;

ANTIBODY STRUCTURE; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CRYSTAL STRUCTURE; DATA BASE; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN CONFORMATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; MOUSE; PROTEIN DATABASE; RAT;

ANIMALS; ANTIBODIES; COMPLEMENTARITY DETERMINING REGIONS; DATABASES, PROTEIN; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION; RATS;

EID: 84904464590     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24559     Document Type: Article

References (28)

1. Kabat EA. The structural basis of antibody complementarity. Adv Protein Chem 1978;32:1-75.
2. Chothia C, Lesk A. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987;196:901-917.
3. Morea V, Lesk AM, Tramontano A. Antibody modeling: implications for engineering and design. Methods 2000;20:267-279.
4. Kuroda D, Shirai H, Kobori M, Nakamura H. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Proteins 2009;75:139-146.
5. North B, Lehmann A, Dunbrack RL. A new clustering of antibody CDR loop conformations. J Mol Biol 2011;406:228-256.
6. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000;28:235-242.
7. Lefranc MP. IMGT, the International ImMunoGeneTics Information System. Cold Spring Harb Protoc 2011;2011:595-603.
8. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ. Conformations of immunoglobulin hypervariable regions. Nature 1989;342:877-883.
9. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 1994;50:760-763.
10. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D 2010;66:486-501.
11. Zhu X, Tanaka F, Hu Y, Heine A, Fuller R, Zhong G, Olson AJ, Lerner RA, Barbas CF, Wilson IA. The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis. J Mol Biol 2004;343:1269-1280.
12. Ni YG, Di Marco S, Condra JH, Peterson LB, Wang W, Wang F, Pandit S, Hammond HA, Rosa R, Cummings RT, Wood DD, Liu X, Bottomley MJ, Shen X, Cubbon RM, Wang SP, Johns DG, Volpari C, Hamuro L, Chin J, Huang L, Zhao JZ, Vitelli S, Haytko P, Wisniewski D, Mitnaul LJ, Sparrow CP, Hubbard B, Carfí A, Sitlani A. A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo. J Lipid Res 2011;52:78-86.
13. Evans DW, Müller-Loennies S, Brooks CL, Brade L, Kosma P, Brade H, Evans SV. Structural insights into parallel strategies for germline antibody recognition of lipopolysaccharide from Chlamydia. Glycobiology 2011;21:1049-1059.
14. Teplyakov A, Obmolova G, Canziani G, Zhao Y, Gutshall L, Jung SS, Gilliland GL. His-tag binding by antibody C706 mimics β-amyloid recognition. J Mol Recognit 2011;24:570-575.
15. Monaco-Malbet S, Berthet-Colominas C, Novelli A, Battaï N, Piga N, Cheynet V, Mallet F, Cusack S. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Structure 2000;8:1069-1077.
16. Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 1997;273:927-948.
17. Vargas-Madrazo E, Paz-García E. Modifications to canonical structure sequence patterns: analysis for L1 and L3. Proteins 2002;47:250-254.
18. Zhou GW, Guo J, Huang W, Fletterick RJ, Scanlan TS. Crystal structure of a catalytic antibody with a serine protease active site. Science 1994;265:1059-1064.
19. Guarné A, Bravo J, Calvo J, Lozano F, Vives J, Fita I. Conformation of the hypervariable region L3 without the key proline residue. Protein Sci 1996;5:167-169.
20. Padavattan S, Schirmer T, Schmidt M, Akdis C, Valenta R, Mittermann I, Soldatova L, Slater J, Mueller U, Markovic-Housley Z. Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. J Mol Biol 2007;368:742-752.
21. Jiang Y, Lee A, Chen J, Ruta V, Cadene M, Chait BT, MacKinnon R. X-ray structure of a voltage-dependent K+ channel. Nature 2003;423:33-41.
22. Yu Y, Schürpf T, Springer TA. How natalizumab binds and antagonizes α4 integrins. J Biol Chem. 2013;288:32314-32325.
23. Teplyakov A, Obmolova G, Malia TJ, Luo J, Gilliland GL. Structural evidence for a constrained conformation of short CDR-L3 in antibodies. Proteins 2014, doi: 10.1002/prot.24522.
24. Blackler RJ, Müller-Loennies S, Brooks CL, Evans DW, Brade L, Kosma P, Brade H, Evans SV. A common NH53K mutation in the combining site of antibodies raised against chlamydial LPS glycoconjugates significantly increases avidity. Biochemistry 2011;50:3357-3368.
25. Brooks CL, Schietinger A, Borisova SN, Kufer P, Okon M, Hirama T, Mackenzie CR, Wang LX, Schreiber H, Evans SV. Antibody recognition of a unique tumor-specific glycopeptide antigen. Proc Natl Acad Sci USA 2010;107:10056-10061.
26. Mage MG, Dolan MA, Wang R, Boyd LF, Revilleza MJ, Robinson H, Natarajan K, Myers NB, Hansen TH, Margulies DH. The peptide-receptive transition state of MHC class I molecules: insight from structure and molecular dynamics. J Immunol 2012;189:1391-1399.
27. Almagro JC, Beavers MP, Hernandez-Guzman F, Maier J, Shaulsky J, Butenhof K, Labute P, Thorsteinson N, Kelly K, Teplyakov A, Luo J, Sweet R, Gilliland GL. Antibody modeling assessment. Proteins 2011;79:3050-3066.
28. Teplyakov A, Luo J, Obmolova G, Malia TJ, Sweet R, Stanfield RL, Kodangatti S, Almagro JC, Gilliland GL. Antibody modeling assessment II: structures and models. Proteins 2014, doi: 10.1002/prot.24554.